{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:18:36Z","timestamp":1770995916362,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,13]]},"DOI":"10.7759\/cureus.103529","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:29:44Z","timestamp":1770992984000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Safety and Efficacy of Avanafil and Tadalafil in the Treatment of Erectile Dysfunction: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Sajal","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nipun","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyog","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat","family":"Shejawadkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abheesh V","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BM Zeeshan","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g129","article-title":"Erectile dysfunction","volume":"348","author":"Muneer A","year":"2014","unstructured":"Muneer A, Kalsi J, Nazareth I, Arya M. Erectile dysfunction. BMJ. 2014, 348:129. 10.1136\/bmj.g129","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60520-0","article-title":"Erectile dysfunction","volume":"381","author":"Shamloul R","year":"2013","unstructured":"Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013, 381:153-65. 10.1016\/S0140-6736(12)60520-0","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1999.00142.x","article-title":"The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences","volume":"84","author":"Ayta IA","year":"1999","unstructured":"Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999, 84:50-6. 10.1046\/j.1464-410x.1999.00142.x","journal-title":"BJU Int"},{"key":"ref4","article-title":"Erectile dysfunction","author":"Leslie SW","year":"2024","unstructured":"Leslie SW, Sooriyamoorthy T. Erectile dysfunction. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.02.166","article-title":"Efficacy and safety of sildenafil by age in men with erectile dysfunction","volume":"13","author":"Goldstein I","year":"2016","unstructured":"Goldstein I, Tseng LJ, Creanga D, Stecher V, Kaminetsky JC. Efficacy and safety of sildenafil by age in men with erectile dysfunction. J Sex Med. 2016, 13:852-9. 10.1016\/j.jsxm.2016.02.166","journal-title":"J Sex Med"},{"key":"ref6","article-title":"Erectile dysfunction","volume":"2011","author":"Khera M","year":"2011","unstructured":"Khera M, Goldstein I. Erectile dysfunction. BMJ Clin Evid. 2011, 2011:1803.","journal-title":"BMJ Clin Evid"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s3336","article-title":"Tadalafil in the treatment of erectile dysfunction","volume":"4","author":"Coward RM","year":"2008","unstructured":"Coward RM, Carson CC. Tadalafil in the treatment of erectile dysfunction. Ther Clin Risk Manag. 2008, 4:1315-29. 10.2147\/tcrm.s3336","journal-title":"Ther Clin Risk Manag"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S57610","article-title":"Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility","volume":"10","author":"Katz EG","year":"2014","unstructured":"Katz EG, Tan RB, Rittenberg D, Hellstrom WJ. Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility. Ther Clin Risk Manag. 2014, 10:701-11. 10.2147\/TCRM.S57610","journal-title":"Ther Clin Risk Manag"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.06.016","article-title":"Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus","volume":"87","author":"Goldstein I","year":"2012","unstructured":"Goldstein I, Jones LA, Belkoff LH, et al.. Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus. Mayo Clin Proc. 2012, 87:843-52. 10.1016\/j.mayocp.2012.06.016","journal-title":"Mayo Clin Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02629.x","article-title":"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction","volume":"9","author":"Goldstein I","year":"2012","unstructured":"Goldstein I, McCullough AR, Jones LA, et al.. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med. 2012, 9:1122-33. 10.1111\/j.1743-6109.2011.02629.x","journal-title":"J Sex Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.11.177","article-title":"A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy","volume":"189","author":"Mulhall JP","year":"2013","unstructured":"Mulhall JP, Burnett AL, Wang R, et al.. A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. J Urol. 2013, 189:2229-36. 10.1016\/j.juro.2012.11.177","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al.. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-7. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14785","article-title":"Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: a randomized, double blind, multicenter clinical trial","volume":"29","author":"Kumar M","year":"2022","unstructured":"Kumar M, Pathade AD, Gupta SV, et al.. Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: a randomized, double blind, multicenter clinical trial. Int J Urol. 2022, 29:351-9. 10.1111\/iju.14785","journal-title":"Int J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen RC","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997, 49:822-30. 10.1016\/S0090-4295(97)00238-0","journal-title":"Urology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-017-1644-5","article-title":"Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis","volume":"49","author":"Gong B","year":"2017","unstructured":"Gong B, Ma M, Xie W, et al.. Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Int Urol Nephrol. 2017, 49:1731-40. 10.1007\/s11255-017-1644-5","journal-title":"Int Urol Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.03.031","article-title":"Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis","volume":"68","author":"Chen L","year":"2015","unstructured":"Chen L, Staubli SE, Schneider MP, et al.. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol. 2015, 68:674-80. 10.1016\/j.eururo.2015.03.031","journal-title":"Eur Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462727-comparison-of-safety-and-efficacy-of-avanafil-and-tadalafil-in-the-treatment-of-erectile-dysfunction-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:29:45Z","timestamp":1770992985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462727-comparison-of-safety-and-efficacy-of-avanafil-and-tadalafil-in-the-treatment-of-erectile-dysfunction-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.103529","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}